References
- Alagia A, Eritja R. 2016. siRNA and RNAi optimization. Wiley Interdiscip Rev RNA. 7:316–329.
- Ataei N, Sabzghabaee AM, Movahedian A. 2015. Calcium/calmodulin-dependent protein kinase II is a ubiquitous molecule in human long-term memory synaptic plasticity: a systematic review. Int J Prev Med. 6:88.
- Barrett PQ, Lu HK, Colbran R, Czernik A, Pancrazio JJ. 2000. Stimulation of unitary T-type Ca(2+) channel currents by calmodulin-dependent protein kinase II. Am J Physiol Cell Physiol. 279:C1694–C1703.
- Bobbin ML, Rossi JJ. 2016. RNA interference (RNAi)-based therapeutics: delivering on the promise? Annu Rev Pharmacol Toxicol. 56:103–122.
- Boric M, Kadic AJ, Ferhatovic L, Sapunar D, Puljak L. 2013. Calcium/calmodulin-dependent protein kinase II in dorsal horn neurons in long-term diabetes. Neuroreport. 24:992–996.
- Chemin J, Traboulsie A, Lory P. 2006. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium. 40:121–134.
- Fakhr E, Zare F, Teimoori-Toolabi L. 2016. Precise and efficient siRNA design: a key point in competent gene silencing. Cancer Gene Ther. 23:73–82.
- Ferhatovic L, Jelicic Kadic A, Boric M, Puljak L. 2014. Changes of calcium/calmodulin-dependent protein kinase II expression in dorsal root ganglia during maturation in long-term diabetes. Histol Histopathol. 29:649–658.
- Iftinca MC, Zamponi GW. 2009. Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci. 30:32–40.
- Kennedy MB, Greengard P. 1981. Two calcium/calmodulin-dependent protein kinases, which are highly concentrated in brain, phosphorylate protein I at distinct sites. Proc Natl Acad Sci USA. 78:1293–1297.
- Liu XB, Murray KD. 2012. Neuronal excitability and calcium/calmodulin dependent protein kinase type II: location, location, location. Epilepsia. 53:45–52.
- Prabha S, Vyas R, Gupta N, Ahmed B, Chandra R, Nimesh S. 2015. RNA interference technology with emphasis on delivery vehicles-prospects and limitations. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1058808.
- Racioppi L, Means AR. 2012. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem. 287:31658–31665.
- Shenas SMM, Mansoori B, Mohammadi A, Salehi S, Kaffash B, Talebi B, et al. 2016. SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.1080/21691401.2016.1198361.
- Van Steenwinckel J, Noghero A, Thibault K, Brisorgueil MJ, Fischer J, Conrath M. 2009. The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons in rat lumbar dorsal root ganglia. Neuroscience. 161:838–846.
- Walwyn W, John S, Maga M, Evans CJ, Hales TG. 2009. Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol. 76:134–143.
- Welsby PJ, Wang H, Wolfe JT, Colbran RJ, Johnson ML, Barrett PQ. 2003. A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J Neurosci. 23:10116–10121.
- Wen X, Xu S, Liu H, Zhang Q, Liang H, Yang C, Wang H. 2013. Neurotoxicity induced by bupivacaine via T-type calcium channels in SH-SY5Y cells. PLoS One. 8:e62942.
- Wen X, Xu S, Zhang Q, Li X, Liang H, Yang C, Wang H, Liu H. 2016. Inhibitory gene expression of the Cav3.1 T-type calcium channel to improve neuronal injury induced by lidocaine hydrochloride. Eur J Pharmacol. 775:43–49.
- Wolfe JT, Wang H, Perez-Reyes E, Barrett PQ. 2002. Stimulation of recombinant Ca(v)3.2, T-type, Ca(2+) channel currents by CaMKIIgamma(C). J Physiol (Lond). 538:343–355.
- Yin K, Baillie GJ, Vetter I. 2016. Neuronal cell lines as model dorsal root ganglion neurons: A transcriptomic comparison. Mol Pain. 12. doi: 10.1177/1744806916646111.
- Zhang Y, Yan L, Cao Y, Kong G, Lin C. 2016. Long noncoding RNA BDNF-AS protects local anesthetic induced neurotoxicity in dorsal root ganglion neurons. Biomed Pharmacother. 80:207–212.